Karlheinz Gast
Chairman bei UCB BioSciences GmbH
Profil
Karlheinz Gast is currently the Chairman at UCB BioSciences GmbH.
He was previously the Chief Executive Officer at APONTIS PHARMA AG from 2021 to 2023, Managing Director at UCB Pharma GmbH from 2016 to 2018, Managing Director-BU Cardiovascular at ASTA Medica AG from 1995 to 1997, Managing Director-Fujisawa BU Respiratory at Klinge Pharma GmbH from 1991 to 1995, and Sales Director at Schwarz Pharma Deutschland GmbH from 1997 to 2007.
He also served as the Managing Director at Apontis Pharma GmbH & Co. KG from 2018 to 2021.
Aktive Positionen von Karlheinz Gast
| Unternehmen | Position | Beginn |
|---|---|---|
UCB BioSciences GmbH
 UCB BioSciences GmbH Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, UCB BioSciences GmbH is a German company that responds to conflicts in the field of biotechnology. The private company is based in Monheim, Germany. The CEOs of the company are Peter Mitterhofer, Eric Schemann. | Chairman | - |
Ehemalige bekannte Positionen von Karlheinz Gast
| Unternehmen | Position | Ende |
|---|---|---|
| APONTIS PHARMA AG | Chief Executive Officer | 10.07.2023 |
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Chief Executive Officer | 01.01.2021 |
| Schwarz Pharma Deutschland GmbH | Sales & Marketing | 01.01.2007 |
| ASTA Medica AG | Corporate Officer/Principal | 01.01.1997 |
Klinge Pharma GmbH
 Klinge Pharma GmbH Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH manufactures pharmaceutical products. It offers Binko, Utipro plus, Venostasin, Andvomex A. The company was founded in 1933 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | 01.01.1995 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Private Unternehmen | 6 |
|---|---|
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
| ASTA Medica AG | Health Technology |
Klinge Pharma GmbH
Klinge Pharma GmbH Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH manufactures pharmaceutical products. It offers Binko, Utipro plus, Venostasin, Andvomex A. The company was founded in 1933 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Schwarz Pharma Deutschland GmbH | |
UCB BioSciences GmbH
UCB BioSciences GmbH Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, UCB BioSciences GmbH is a German company that responds to conflicts in the field of biotechnology. The private company is based in Monheim, Germany. The CEOs of the company are Peter Mitterhofer, Eric Schemann. | Commercial Services |
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
